BioCentury
ARTICLE | Company News

ActoGeniX, Stallergenes deal

December 16, 2013 8:00 AM UTC

The companies partnered to develop allergy treatments using ActoGeniX's ActoBiotics mucosal delivery technology. ActoGeniX will develop clinical ActoBiotic candidates that express undisclosed predefin...